KCNA4 and Arrhythmia: miR-155 might directly influence arrhythmia outcomes by targeting critical ion channel gene expression, including CACNA1C and KCNA4, which encode the cardiac L-type Ca2+ channel (ICaL) α1c and the initial component of the transient outward potassium current (Ito1), respectively.